Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family - PubMed (original) (raw)
Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family
M E Furth et al. J Virol. 1982 Jul.
Abstract
We have isolated eight rat lymphocyte-myeloma hybrid cell lines producing monoclonal antibodies that react with the 21,000-dalton transforming protein (p21) encoded by the v-ras gene of Harvey murine sarcoma virus (Ha-MuSV). These antibodies specifically immunoprecipitate both phosphorylated and non-phosphorylated forms of p21 from lysates of cells transformed by Ha-MuSV. All eight react with the products of closely related ras genes expressed in cells transformed by two additional sarcoma viruses (rat sarcoma virus and BALB sarcoma virus) or by a cellular Harvey-ras gene placed under the control of a viral promoter. Three of the antibodies also react strongly with the p21 encoded by the v-ras gene of Kirsten MuSV. These same three antibodies immunoprecipitate the predominant p21 species synthesized normally in a variety of rodent cell lines, including the p21 produced at high levels in 416B murine hemopoietic cells. This suggests that an endogenous gene closely related to Kirsten-ras is expressed in these cells. The monoclonal antibodies have been used to confirm two properties associated with p21; localization at the inner surface of the membrane of Ha-MuSV-transformed cells, assayed by immunofluorescence microscopy, and binding of guanine nucleotides.
Similar articles
- Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus.
Shih TY, Weeks MO, Young HA, Scholnick EM. Shih TY, et al. Virology. 1979 Jul 15;96(1):64-79. doi: 10.1016/0042-6822(79)90173-9. Virology. 1979. PMID: 223311 - Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes.
Papageorge A, Lowy D, Scolnick EM. Papageorge A, et al. J Virol. 1982 Nov;44(2):509-19. doi: 10.1128/JVI.44.2.509-519.1982. J Virol. 1982. PMID: 6292515 Free PMC article. - Oncogenes and cancer: the p21 ras genes.
Shih TY, Weeks MO. Shih TY, et al. Cancer Invest. 1984;2(2):109-23. doi: 10.3109/07357908409020294. Cancer Invest. 1984. PMID: 6375822 Review. No abstract available. - A perspective on the early days of RAS research.
Weiss RA. Weiss RA. Cancer Metastasis Rev. 2020 Dec;39(4):1023-1028. doi: 10.1007/s10555-020-09919-1. Epub 2020 Jul 29. Cancer Metastasis Rev. 2020. PMID: 32728828 Free PMC article. Review.
Cited by
- Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications.
Chan A, Tsourkas A. Chan A, et al. BME Front. 2024 Jan 25;5:0035. doi: 10.34133/bmef.0035. eCollection 2024. BME Front. 2024. PMID: 38282957 Free PMC article. Review. - RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP.
Lin P, Qian J, Huang CC, Xu WM, Wang YY, Gao ZR, Zheng SQ, Wang P, Jia DQ, Feng Q, Yang JL. Lin P, et al. BMC Cancer. 2024 Jan 12;24(1):71. doi: 10.1186/s12885-023-11686-5. BMC Cancer. 2024. PMID: 38216883 Free PMC article. - Targeting the "undruggable" RAS with biologics.
Whaby M, Khan I, O'Bryan JP. Whaby M, et al. Adv Cancer Res. 2022;153:237-266. doi: 10.1016/bs.acr.2021.07.006. Epub 2021 Aug 13. Adv Cancer Res. 2022. PMID: 35101232 Free PMC article. Review. - Biology, pathology, and therapeutic targeting of RAS.
Rhett JM, Khan I, O'Bryan JP. Rhett JM, et al. Adv Cancer Res. 2020;148:69-146. doi: 10.1016/bs.acr.2020.05.002. Epub 2020 Jul 9. Adv Cancer Res. 2020. PMID: 32723567 Free PMC article. Review. - An ultra-stable cytoplasmic antibody engineered for in vivo applications.
Kabayama H, Takeuchi M, Tokushige N, Muramatsu SI, Kabayama M, Fukuda M, Yamada Y, Mikoshiba K. Kabayama H, et al. Nat Commun. 2020 Jan 17;11(1):336. doi: 10.1038/s41467-019-13654-9. Nat Commun. 2020. PMID: 31953402 Free PMC article.
References
- J Bacteriol. 1966 Oct;92(4):1133-40 - PubMed
- J Virol. 1969 Nov;4(5):549-53 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- J Natl Cancer Inst. 1974 Dec;53(6):1725-9 - PubMed
- Nature. 1975 Aug 7;256(5517):495-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials